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The study of human B-lymphocyte function in normal and disease states has been 
hindered  by the failure of these cells to be activated to proliferation by classical B- 
lymphocyte mitogens, such as lipopolysaceharide endotoxin (LPS, 1 dextran sulfate, or 
purified  protein  derivative  (PPD)  (1-4).  Human  peripheral  blood  lymphocytes 
(HPBL)  are activated by phytohemagglutinin  (PHA),  pokeweed mitogen  (PWM), 
and staphylococcal protein A (SPA) (5-10). Of these mitogens, PHA, PWM, and SpA 
all have been reported to stimulate both T  and B lymphocytes, and the activation of 
B cells by PWM, and PHA appears to be thymus dependent  (7, 9-11). Because these 
mitogens stimulate both major classes of lymphocytes, it is impossible to rapidly assess 
B-lymphocyte function in unseparated cell cultures. 
The  only  method  presently  available  for  studying  the  function  of  human  B 
lymphocytes  is  that  of  polyclonal  activation  (PCA)  as  determined  by  antibody 
production in vitro (12).  However, this procedure requires rather lengthy periods of 
culture compared to proliferation techniques. PCA has been described in lymphocytes 
isolated from tonsils and peripheral blood (12-14).  It has been shown that PWM is 
more stimulatory  for these  cells  than  LPS,  PPD,  and  dextran  sulfate  (12,  13),  but 
PCA by PWM was found to be highly T-cell dependent  (14). 
Recently a  new protein mitogen has been described which is a potent activator of 
B lymphocytes of mice (15).  This material which is found associated with the LPS in 
the  outer  membrane  of Gram-negative bacteria  is  called  endotoxin  protein  (EP). 
Furthermore, it stimulates the lymphocytes of rats, rabbits, guinea pigs and is also a 
mitogen for HPBL (16). In this paper, we report that it is the human B lymphocytes 
in the absence of T  cells which are stimulated to DNA synthesis by EP. Furthermore 
EP is able to induce PCA in HPBL as shown by the production of antibodies against 
both sheep erythrocytes (SRBC), and 2,4,6  trinitrophenyl-conjugated  SRBC  (TNP- 
SRBC). 
* Supported  in  part  by Biomedical Research Support grant  5SO74405401, Division of Research 
Resources, National Institutes of Health. 
Present address: Department of Microbiology  and Immunology,  Albany Medical Center, Albany, N. 
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LPS, protein-free lipopolysaecharide endotoxin; LPS-B, Boivin lipopolysaccharide endotoxin; NWSM, 
nocardia water soluble mitogen; PBSA, phosphate-buffered saline with 10 mM sodium azide; PCA, 
polyclonal activation; PFC, plaque-forming cells; PHA, phytohemagglutinin-P; PPD, purified protein 
derivative; PWM, pokeweed  mitogen; sIg, surface immunoglobulin; SpA, staphylococcal  protein A; SRBC, 
sheep erythrocytes;  TNP-SRBC, trinitrophenyl conjugated sheep erythrocytes. 
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Materials and Methods 
Human  Cell Suspensions.  Heparinized  venous blood was drawn  from normal  healthy adult 
volunteers, and purified lymphocytes were obtained by the method of Hypaque-Ficoll density 
gradient centrifugation  (T7). Ficoll-Hypaque was purchased from Pharmacia Fine Chemicals, 
Inc., Piscataway, N.J. and sterile 50% hypaque sodium diatriozate solution was obtained from 
Winthrop Laboratories, New York. After separation, lymphocytes were washed twice in RPMI- 
1640 (Grand Island Biological Co., Grand Island, N.Y.) before use. 
Lymphocyte Cultures.  Human lymphocytes were cultured in RPMI-1640 supplemented with 
100  IU/ml  penicillin  and  100  #g/ml  streptomycin.  Unless  otherwise  specified,  cells  were 
suspended  at 8  ×  106 viable cells per ml and 0.05 ml of the suspension was added per well of 
a  microtiter plate  (Flow Laboratories  Inc.,  Rockville, Md.).  An equal volume of mitogen  in 
RPMI-1640 was added to the cell suspensions.  In one experiment,  1 ml of cells was cultured at 
a  concentration of 2  ×  106 cells per ml in  12  ×  75  mm plastic tubes  (Beckman Instruments, 
Inc., Fullerton, Calif.) and 0.1  ml of mitogen diluted in RPMI-1640 was added to the cultures. 
Cells were normally cultured without serum, but in certain experiments 5% pooled human AB 
sera  (615AB,  Grand  Island  Biological Co.)  or fetal calf serum  (E064421,  E172615,  GIBCO) 
were used. All cultures were incubated at 37°C in an atmosphere of 10% CO2 in humidified air 
for 72 h and  1 ~Ci of [3H]thymidine (5Ci/mmole, Amersham Corp., Arlington Heights Ill.) was 
added  for the last  20 h  of culture.  Cells cultured  in microtiter plates were harvested on glass 
fiber filter papers (H. Reeve Angel & Co., Inc. Clifton, N.J., grade 934 AH) with an automated 
sampler  (Otto Hiller Co., Madison, Wis.). Cells cultured  in tubes were harvested on nitrocel- 
lulose ester filters by using a  multimanifold sampler and washed with  15 ml of cold saline and 
5  ml  of cold  trichloracetic  acid.  The  samples  were  dried  and  counted  by  means  of liquid 
scintillation with a  Beckman LS-250  (Beckman Instruments,  Inc.). Cell cultures were done in 
triplicate and replicate values did not differ by more than  5-10%. The results are reported as 
mean counts per minute or stimulation index (SI). The SI was calculated as the ratio of counts 
per minute of the stimulated cultures to counts per minute of the control cultures. 
Human  Cell Separations.  T  and  B  lymphocytes  were  separated  by  the  SRBC  method  of 
Jondal et al. (18).  Briefly, lymphocytes were suspended in fetal calf serum at a concentration of 
5  x  106 cells per ml and mixed with an equal volume of 1% SRBC in fetal calf serum. The cell 
mixture was pelleted by low speed centrifugation and incubated at 37°C for 15 min and then 
at  4°C  for  60  min.  The  cell pellet was  gently resuspended,  layered  on  an  equal  volume of 
Ficoll-Hypaque  and,  spun  at  700  g  for  12  min.  The  cells  at  the  interface  were  harvested, 
washed, and the separation procedure repeated.  Enriched T  lymphocytes were recovered from 
the first erythrocyte pellet by osmotic lysis (19),  and enriched  B  lymphocytes were recovered 
from the interface layer of the second separation.  Both populations of cells were washed twice 
in RPMI-1640 and after washing, the cells in both populations were resuspended,  counted for 
viability by eosin dye exclusion, and cultured in microtiter plates as described above. 
Immunofluorescence.  HPBL were cultured  for  72  h  with or without  mitogen before labeling 
with  fluoresceinated  goat  anti-human  Ig  F(ab')2  fragment  (N.L.  Cappel  Laboratories,  Inc. 
Cochranville, Pa.). After culture, the cells were centrifuged and the pellet resuspended in 0.1  ml 
of phosphate-buffered saline with  10 mM sodium azide (PBSA). Fluoresceinated antibody (0.5 
ml), which had been diluted  1:2 in 5% bovine serum albumin containing 10 mM sodium azide, 
was added  to 2  ×  106 cells. The mixture was incubated  at room temperature  for 20 min and 
washed three times with  PBSA. The pellet was brushed  onto glass slides and Wright-Giemsa 
stained  (20).  The slides were counted  and  scored  for blast  cells and  for fluorescence using a 
Zeiss fluorescent microscope (2-F1, West Germany). 
Polyclonal Activation.  PCA of human  peripheral  blood  lymphocytes was  performed  as  de- 
scribed by Fauci and Pratt (12,  13). Briefly, 2  ×  10  6 cells were cultured with or without mitogen 
with fresh, heat inactivated (56°C for 30 min) pooled type AB or type A human serum, which 
had been SRBC absorbed  (12).  The cell cultures were incubated in an atmosphere of 5% CO2 
in humidified air at 37 ° for 6 d. At this time, the cells were harvested and plaque-forming cells 
(PFC)  enumerated  in a  modified hemolytic plaque assay  (21)  against  SRBC and TNP-SRBC 
(22). 
Mitogens.  Boivin LPS  (LPS-B)  was extracted  from Salmonella typhosa 0-901,  and Salmonella 
typhimurium W118-2 by trichloracetic acid (20).  EP was prepared from these LPS-B preparations GAIL W.  GOODMAN AND BARNET M.  SULTZER 
TABLE  I 
Lymphocyte Activation by EP 
715 
[aH]thymidine  uptake  Mean stimulation 
Donors  Mitogen  Mean cpm (range)  index (range) 
Total*  --  1,002  (484-  2,968)  -- 
PHA 1:800  25,468 (14,830-49,049)  28.4 (11.5-43.4) 
E. coliEP25#g$  4,334  (1,776-9,172)  5.8  (2.1-11.1) 
S. typhosa EP 25 #g§  11,320  (3,019-24,019)  12.7  (3.8-20.1) 
ImmunizedU 
Nonimmunized¶ 
--  833  (579-  1,376)  -- 
PHA 1:800  20,402 (15,817-31,923)  25.0 (21.9-27.7) 
E. coli EP 25/~g  5,781  (2,942-  8,027)  7.7  (2.1-11.1) 
S. typhosa EP 25/tg  10,856  (9,789-11,775)  14.5  (8.2-18.3) 
--  1,142  (484-  2,968)  -- 
PHA 1:800  27,494 (14,830-4%049)  29.8 (11.5-43.4) 
E. coh EP 25 #g  4,335  (1,776-  9,172)  5.8  (2.7-  8.9) 
S. typhosa EP 25,ag  12,484  (3,019-24,019)  12.0  (3.8-20.1) 
* 14 individuals. 
:l: EP lot 1176. 
§ EP lot 1276. 
II Four individuals immunized to S. typhosa from 1 to 6 yr previously. 
¶ 10 unimmunized individuals. 
and Escherichia  coli 0127:B8  as previously described  (15).  Phenol extracted  LPS was prepared 
by  the  method  of Westphal  et  al.  (23).  All  preparations  were  analyzed  for  protein  by  the 
method of Lowry et al. (24). LPS-B from S.  typhosa 0-901  (lot 8178)  and S. typhimurium  W118-2 
(lot  8578)  contained  14.2%  and  20.8%,  protein,  respectively.  The  phenol  LPS  from  these 
organisms contained less than  1% protein. S.  typhosa 0-901  EP contained 83% protein (lot  1276) 
or 85% protein (lot 9578); E. coil 0127:B8 E P (lot 1176) contained 88% protein and S. typhimurium 
W118-2  EP  (lot  9778)  was  composed  of 82.5%  protein.  Lyophilized PHA and  PWM  (Difco 
Laboratories, Detroit, Mich.) were reconstituted to their original volumes. PHA was used at the 
dilutions indicated and  PWM  was assayed  at  final dilutions of 1/50,  1/100,  and  1/500.  The 
optimal response of cells from each individual to these mitogens is reported. PPD (RT-33) was 
purchased  from  Statens  Serum  Institute,  Copenhagen,  Denmark  and  used  as  previously 
described  (21). 
Results 
The  ability  of lymphocytes  from  normal  healthy  adults  to  respond  to  EP  are 
summarized in Table I. Under serum-free conditions, all of the lymphocyte cultures 
were able to respond to PHA and both EP preparations, although the optimal dose 
of EP varied from 25 to 50 ~g/well depending upon the individual. It was previously 
reported that S. typhosa  0-901 EP stimulated a greater incorporation of [aH]thymidine 
than did E. coli 0127:B8 EP at all concentrations and in every lymphocyte preparation 
tested  (16).  This was so whether  the lymphocytes were  from individuals  previously 
immunized to S. typhosa  or from nonimmunized subjects (Table I). Furthermore there 
was no significant difference in stimulation between the normal and typhoid immu- 
nized groups to S.  typhosa  EP  (t  ---  0.98,  13 degrees of freedom, P  >  0.2),  indicating 
that prior immunization to S.  typhosa  did not alter the lymphocyte response. 
Culture  Conditions.  Under serum-free conditions,  the optimum response of HPBL 
to these mitogens peaked at day 3 or 4 (Fig.  1) and decreased thereafter. However, in 
the presence of 5% human serum, the ability of HPBL to respond to stimulation by 716  ACTIVATION  OF  HUMAN  LYMPHOCYTES  BY  ENDOTOXIN  PROTEIN 
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Fie.  I.  SI of HPBL  in response to EP at various days after initiation of culture, 0; donor 1 without 
serum; O  donor 1 and 5% human  serum; 0-  -  -0;  donor 2  without serum; O- -  -O;  donor 2  with 
5% human  serum. 
EP was totally suppressed (Fig.  1). Because human lymphocytes generally are cultured 
in  the presence of serum,  this phenomenon was investigated  further.  The results  in 
Table  II show  that  5%  pooled  human  serum  significantly  inhibits  the  response  of 
HPBL to both S. typhosa and E. coli EP. In contrast, the response of these cells to PHA 
is increased at least  1.5-2 times that of unsupplemented cultures in terms of both cpm 
and stimulation indices.  Fetal calf serum can also increase the stimulation of HPBL 
by PHA (Table III), but these particular lots do not change the response of human 
lymphocytes to EP. 
To further investigate the role of cultural conditions on the response of HPBL to 
EP, the lymphocytes were cultured in plastic tubes at a concentration of 2  X  106 cells 
per ml in the absence of serum supplementation.  In addition, two different lots of S. 
typhosa  0-901  EP  (1276,  9578), one preparation of S.  typhirnurium  Wl18-2 EP  (9778), 
and Boivin preparations from both organisms were tested. The results shown in Table 
IV demonstrate that these conditions are able to support the proliferation of HPBL 
in response to EP and PHA. In addition, HPBL are stimulated by preparations LPS- 
B, but not by protein-free LPS (data not shown). The response of HPBL to 100 lug of 
LPS-B is in most cases,  approximately equal to the response of these cells  to  10 lug of 
EP and generally is ~50% of the optimal EP response. However, in lymphocytes from 
two donors (G.G.  and M.S.)  the response to S.  typhosa  0-901  LPS-B is ~90% of that 
obtained with EP. GAIL  W.  GOODMAN  AND  BARNET  M.  SULTZER 
TABLE  II 
Suppression of the Mitogenic Response of HPBL to EP by Pooled  Human AB Serum* 
[aH]thymidine uptake 
Mean cpm (SI)  S. typhosa EP§ 25 
Donor  Serum  Control  /~g 
PHA 1:800  E. coli EP:]: 25 #g 
717 
J.B.  -  1,376  31,923  (23.2)  2,924 (2.1)  11,289  (8.2) 
+  1,204  95,871  (79.6)  1,359  (1.1)  1,563  (1.3) 
M.S.  -  1,306  39,904  (30.6)  9,175 (7.0)  24,019 (18.4) 
+  1,556  84,118  (54.1)  5,704 (3.7)  8,801  (5.7) 
I.K.  -  750  22,624  (30.2)  5,162 (6.9)  15,104  (20.1) 
+  1,126  54,432  (48.3)  4,523 (4.0)  4,794  (4.3) 
B.M.  -  889  22,313  (25.1)  3,797  (4.3)  9,407 (10.6) 
+  1,059  73,202  (69.1)  1,201  (hl)  2,624  (2.5) 
J.G.  -  593  25,710  (43.4)  2,151  (3.6)  3,019  (5.1) 
+  1,291  79,788  (61.8)  986 (0.8)  2,660  (2.1) 
S.G.  -  2,748  20,008  (7.3)  9,809 (3.6)  15,453  (5.6) 
+  1,593  41,105  (25.8)  2,106 (1.3)  2,789  (1.7) 
* Grand Island Biological Co. human  serum  (lot 615AB)  used at a concentration  of 5% after heat 
inactivation at 56°C for 30 min. 
EP lot 1176. 
§ EP lot 1276. 
TABLE  III 
Effect of Fetal Calf Serum* on the Response of HPBL to S. typhosa EP~ 
Donor  Mitogen 
[3H]thymidine uptake 
Mean cpm (SI) 
None  FCS 5%  FCS 10% 
G.G. 
G.C. 
J.G. 
M. S. 
--  1,473  1,226  1,I 19 
PHA,  1:800  13,429  (9.1)  31,758 (25.9)  33,434  (29.9) 
EP, 50 #g  14,888 (10.1)  16,74l  (13.7)  14,230 (12.7) 
--  1,497  1,196  1,434 
PHA,  1:800  6,046  (4.0)  15,270 (12.8)  32,928  (23.0) 
EP, 50#g  ll,298  (7.5)  13,735 (11.4)  9,302  (6.5) 
--  1,803  870  1,100 
PHA,  1:800  4,396  (2.5)  9,355 (10.8)  29,715  (27.0) 
EP, 50p.g  6,493  (3.6)  6,136  (7.1)  6,226  (5.7) 
--  1,931  1,488  1,609 
PHA,  1:800  5,005  (2.6)  20,963  (14,0)  32,707  (20.3) 
EP, 50p.g  21,926  (11.4)  19,077 (12.8)  17,987  (11.2) 
* FCS, fetal calf serum. Grand Island Biological Co. lot E064421.  Similar results seen with 
lot El72615. 
:~ EP lot 1276. 
Responding Cell  In  mice,  EP  is  a  B-lymphocyte mitogen  (15).  Therefore it  was 
essential to determine what class of lymphocytes in human lymphocytes cultures was 
responding to stimulation by EP. The data of Table V show that the majority of cells 
which had undergone blast transformation in response to EP were lymphocytes which 
possessed surface immunoglobulin (sIg). Even in cultures of enriched T  lymphocytes, 
where only 6% of the cells were sIg positive 62% of the cells which were transforming 718  ACTIVATION OF  HUMAN LYMPHOCYTES  BY  ENDOTOXIN  PROTEIN 
TABLE IV 
Response  of HPBL Cultured in  Tubes to EP* 
[aH]thymidine uptake 
Donor  B.M.:~  Mean cpm (SI)  G.C.§  J.B.§ 
O.O.§  M.S.§ 
Mitogen 
Con  960  1,642  1,398  1,221  988 
PHA 1/800  10,645 (11.1)  43,774  (26.7)  54,323  (38.9)  22,849  (18.7)  24,475  (24.8) 
1/1600  16,795 (17.5)  52,460  (31.9)  75,576  (54.1)  39,552  (32.4)  33,285  (33.7) 
1/2400  ND]I  71,270 (43.4)  62,901  (45.0)  41,173  (33.7)  35,826  (36.3) 
S. typhosa 
EP 10#g/ml  3,578  (3.7)  7,303  (4.4)  5,315  (3.8)  2,482  (2.0)  3,327  (3.4) 
50#g/ml  9,709(10.1)  8,396  (5.1)  7,757  (5.5)  4,900  (4.0)  4,361  (4.4) 
100#g/ml  13,592(14.2)  8,389  (5.1)  8,197  (5.9)  6,328  (5.2)  4,757  (4.8) 
LPS-B  100#g/ml  ND  7,621  (4.6)  7,243  (5.2)  3,188  (2.6)  3,303  (3.3) 
S. typhimurium 
EP10#g/ml  ND  6,751  (4.1)  5,880  (4.2)  2,149  (1.8)  2,92l  (2.9) 
50#g/ml  ND  8,815  (5.4)  9,649  (6.9)  4,108  (3.4)  4,392  (4.4) 
100#g/ml  ND  8,984  (5.5)  9,221  (6.6)  4,826  (4.0)  4,360  (4.4) 
LPS-B  100#g/ml  ND  6,510  (4.0)  5,200  (3.7)  2,541  (2.1)  2,429  (2.5) 
* Cells were cultured at 2 ×  106 cells/ml. 
S. typhosa EP lot 1276. 
§ S. typhosa EP lot 9578, S. typhimurium EP lot 9778; S. typhosa LPS-B lot 8178, S. typhimurium LPS-B lot 8578 
IIND, not done. 
TABLE V 
Blastogenesis of HPBL in Response to EP 
Mean number of blast cells per 100 cells* 
Cell type  sIg+ cells  Control  PHA 
per 100 cells 
S. typhosa EP~ 
sIg-  sIg+  sIg-  sIg+  sIg-  sIg+ 
Unseparated  27  3.2  1.7  ND§  ND  2.7  13.3 
B-enriched  92  1.1  8.4  3  12  0.9  36.4 
T-enriched  5  7.6  0.5  38.8  1.2  4.7  7.6 
* 400 cells per slide in triplicate were counted for each group for a total of 1,200 cells counted per 
group. 
§ ND, not done. 
EP lot  1276. 
in response to EP were slg positive. In addition, the percent of Ig-positive transformed 
cells in unseparated preparations increased by more than two times the control value 
when  the  cells were  cultured  with  EP.  These  data  are  strongly  suggestive  that  EP 
stimulates human  B  lymphocytes. 
Further cell separation studies were done to verify the original data. Six individuals 
were tested and the results (Fig. 2)  demonstrate that  after the removal of T  lympho- 
cytes, the remaining B-enriched cells (>94% sIg positive) were able to respond to EP, 
but were not stimulated by PHA. The T-enriched cells (>94% sIg negative) were able 
to  proliferate  when cultured with  PHA.  There  was  variation in the response to  EP 
and  PHA  from  individual to individual; however,  in all cases,  the stimulation of B- 
enriched cells by EP was significantly above background  (SI >  4.5). GAIL  W.  GOODMAN  AND  BARNET  M.  SULTZER 
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Flo,  3.  Polyclonal activation of EP. The results are reported  for the optimal doses  of PWM.  All 
other  mitogens  were  tested  at  100 #g/mL  •  anti-SRBC  plaques;  •  anti-TNP-SRBC  plaques. 
Background for anti-TNP-SRBC plaques was 0. 
Although  all of this evidence  suggests  thymus-independent  cells are proliferating  in 
the  presence  of  EP,  the  sine  qua  non  of  B-cell  activation  is  antibody  production. 
Therefore,  if  EP  could  nonspecifically  activate  clones  of  B  lymphocytes  to  make 
antibody  to diverse antigens,  then it would be assured that EP was stimulating human 
B  lymphoeytes.  The  results  of PCA  experiments  are  shown  in  Fig.  3.  Three  different 
S. typhosa EP preparations  (1678,  2578,  9578)  and S. typhimurium EP 9778  were able to 
stimulate  PCA.  In addition,  PWM  stimulated  PCA  in most of the individuals  tested. 
More  interestingly,  EP  preparations  9578  and  9778  stimulated  approximately  twice 720  ACTIVATION OF  HUMAN  LYMPHOCYTES  BY  ENDOTOXIN  PROTEIN 
as  many PFC  than  did  PWM  when  assayed against  SRBC  and TNP-SRBC.  LPS 
and PPD also stimulated nonspecific antibody production, but to a lesser degree than 
any of the other mitogens, confirming the results of Fauci and Pratt and Fauci et al. 
(12,  13). 
Discussion 
It is clear from the data presented that EP is a mitogen and polyclonal activator of 
human  B  lymphocytes. The mitogenic stimulation  by EP  is optimal at  2-4 d, and 
may be  suppressed  by the  addition  of pooled  human  AB  serum.  In  studies  to  be 
reported elsewhere,  it has been demonstrated  that  the inhibition  of the response of 
HPBL to EP is not due to antibody directed against EP. In contrast to human serum, 
fetal calf serum does not suppress the proliferative response of HPBL to EP. 
That the response of HPBL to EP is nonspecific has been demonstrated in several 
ways. First, the response of individuals who had been deliberately immunized against 
typhoid was not significantly different from that of nonimmunized controls. Second, 
the optimal mitogenic response to EP appears early in culture for all the individuals 
tested, unlike the response to specific antigens which takes 6-7 d  (25-27). Finally, EP 
was able to stimulate polyclonal activation in HPBL, which by definition is nonspe- 
cific. 
In  mice,  the  dissociation  of  proliferation  from  polyclonal  activation  has  been 
demonstrated (27-29). That this may be so in human lymphocytes as well is suggested 
by the difference between the kinetics of proliferation and that of polyclonal activa- 
tion. As with PWM, EP activates peak mitogenesis in HPBL at 3 d, while PCA is not 
optimal until  6 d  (13).  Additional  evidence in support of the dichotomy of response 
is that although pooled AB serum suppressed the proliferative response to EP, it was 
required  for  activation  of PFC.  In  addition,  lymphocytes from only  ~70%  of the 
individuals  tested were stimulated  to produce antibody by PWM,  even though  the 
cells  from all  donors  were able  to proliferate when  cultured  with  this  mitogen  (A. 
Fauci and G. Whalen, personal communications). Apparently in humans as in mice, 
nonspecific activation of PFC is not dependent upon proliferation. 
In  contrast  to  the  numerous  reports  in  the  literature  of the  inability  of LPS  to 
stimulate  proliferation  i~  HPBL,  EP,  which  is  found  associated  with  LPS  in  the 
bacterial outer membrane, is active. It is interesting to note that in our hands LPS-B, 
but not  LPS, can activate HPBL. This suggests that the stimulation  of HPBL by a 
commercially prepared LPS described by Hsu  (30)might be due to protein contam- 
ination  of these preparations.  Activation of human lymphocytes by LPS-B, but  not 
by  protein-free  LPS,  supports  our  position  that  the  protein  content  of  all  LPS 
preparations should be determined so that the component responsible for lymphocyte 
activation is clearly defined. 2 
We  observed  that  different  EP  preparations  have  various  activities  on  human 
lymphocytes  (16).  For example, the  mitogens EP  1176,  1276,  9578,  and  9778  were 
extracted from bacteria grown in shaker flasks, but two other preparations,  1678 and 
2578, were grown in 90-liter fermentation tanks. Although the latter preparations are 
not  able  to  induce  proliferation  in  human  lymphocytes, they  can  stimulate  PCA. 
Thus, different  bacterial  growth conditions  result  in EP preparations with different 
2 Goodman,  G.  W.,  and  B.  M.  Sultzer.  1979. Further studies on  the  activation  of lymphocytes by 
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activities on human lymphocytes. Additionally, Schnaitman has shown that different 
conditions of bacterial growth result in differences in the composition of the proteins 
found in the outer membrane (31), an observation confirmed by us using polyacryl- 
amide gel electrophoresis  (16).  In studies  in progress, different  EP preparations are 
being separated into their polypeptide components. We believe that these experiments 
will  reveal  which  of the  proteins  in  this  heterogeneous  complex  is  responsible  for 
activating HPBL. 
At  present,  there  has  been  only one other mitogen,  Nocardia  opaca  water soluble 
mitogen  (NWSM), which has been described as a  nonspecific activator of human B 
lymphocytes but  not  T  cells  (32,  33).  NWSM  is  a  peptidoglycan  which  activates 
lymphocytes from primates, mice and rabbits, as well as man (34, 35). However, there 
appears to be a number of functional differences between this mitogen and EP. PCA 
induced by NWSM is considerably less than that induced by EP and peak mitogenic 
stimulation  by NWSM  is  observed at  5  d,  whereas  the peak proliferative response 
induced  by EP  is  seen  at  3  d.  It will  be interesting  to compare these  materials  in 
parallel  and  to  determine  whether  the  B  lymphocytes  subpopulations  that  are 
activated are the same. 
In conclusion,  the application of EP in the comparative analysis of human B-cell 
function in the normal and disease states appears to be promising. 
Summary 
Endotoxin protein  (EP)  has been shown to be a  mitogen and polyclonal activator 
of human peripheral blood lymphocytes. EP stimulates proliferation of B lymphocytes 
in the absence ofT cells, and this activation is nonspecific by a number of parameters. 
Additionally,  EP  mitogenesis,  but  not  polyclonal  activation,  is  inhibited  in  the 
presence of human serum, suggesting that these events are dissociable. In these studies, 
EP  appears  to  be  equivalent  to  or  better  than  pokeweed  mitogen  in  stimulating 
nonspecific antibody production in vitro. 
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